Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-wide measures of DNA methylation in peripheral blood and the risk of urothelial cell carcinoma: a prospective nested case–control study

4 Aug 2016

Abstract excerpt

BACKGROUND: Global DNA methylation has been reported to be associated with urothelial cell carcinoma (UCC) by studies using blood samples collected at diagnosis. Using the Illumina HumanMethylation450 assay, we derived genome-wide measures of blood DNA methylation and assessed them for their prospective association with UCC risk. METHODS: We used 439 case-control pairs from the Melbourne Collaborative Cohort...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27490804
DOI: 10.1038/bjc.2016.237

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-wide measures of DNA methylation in peripheral blood and the risk of urothelial cell carcinoma: a prospective nested case–control studyPMID 27490804Read ↗

DNA Methylation Array Analysis Identifies Profiles of Blood-Derived DNA Methylation Associated With Bladder CancerSemantic proximity Read ↗

Genome‐Wide Measures of Peripheral Blood Dna Methylation and Prostate Cancer Risk in a Prospective Nested Case‐Control StudySemantic proximity Read ↗

Diagnostic markers of urothelial cancer based on DNA methylation analysisSemantic proximity Read ↗

Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancerSemantic proximity Read ↗

Integrative epigenomic analysis of differential DNA methylation in urothelial carcinomaSemantic proximity Read ↗

A global profile of gene promoter methylation in treatment-naïve urothelial cancerSemantic proximity Read ↗

Genome‐wide DNA methylation profiles in urothelial carcinomas and urothelia at the precancerous stageSemantic proximity Read ↗

Non-invasive diagnosis for urothelial carcinoma using a dual-target DNA methylation biomarker panelSemantic proximity Read ↗

Identification of Methylated Genes Associated with Aggressive Bladder CancerSemantic proximity Read ↗

Detection of genome-wide methylation changes in bladder cancer by long-read sequencing of urinary DNASemantic proximity Read ↗

MicroRNA promoter methylation: a new tool for accurate detection of urothelial carcinomaSemantic proximity Read ↗

Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor MarkersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.